Download presentation
Presentation is loading. Please wait.
Published byAriel Kelley Modified over 5 years ago
1
Changes in secondary outcome measures from baseline to 18 weeks (Gp, group; VAS, visual analogue scale).The beneficial effect of VSL#3 seems to be maintained throughout the 18 weeks study period, observed as continued significant improvement in stool frequency, stool mucus and well-being. . Changes in secondary outcome measures from baseline to 18 weeks (Gp, group; VAS, visual analogue scale).The beneficial effect of VSL#3 seems to be maintained throughout the 18 weeks study period, observed as continued significant improvement in stool frequency, stool mucus and well-being. Sarika Rohatgi et al. BMJ Open Gastroenterol 2015;2:e000018 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.